Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 846-851

  Flego, Veljko ^a   Ristić, Smiljana ^b   Dević Pavlić, Sanja ^b   Matanić Lender, Dubravka ^a   Bulat Kardum, Ljiljana ^b   Kapović, Miljenko ^a   Radojčić Badovinac, Andjelka ^b,c  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c University of Rijeka   (Croatia)

Author keywords

Carcinogenesis; Lung cancer; Molecular epidemiology; Second primary tumor; TNF polymorphism

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TUMOR NECROSIS FACTOR ALPHA 238 GENE; TUMOR NECROSIS FACTOR ALPHA 308 GENE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CROATIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885351443     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889554     Document Type: Article

References (20)

1. Gursel B, Meydan D, Özbek N et al: Multiple primary malignant neoplasms from the black sea region of Turkey. J Int Med Res, 2011; 39: 667-74
2. Alberts DS: Second cancers are killing us? Cancer Epidemiol Biomarkers Prev, 2006; 15(11): 2019
3. Nielsen SF, Nordestgaard BG, Bojesen SE: Associations between first and second primary cancers: a population-based study. CMAJ, 2012; 184(1): E57-69
4. Olsen JH, Moller T, Anderson H et al: Lifelong cancer incidence in 47 697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst, 2009; 101: 806-13
5. Karahalios E, English D, Thursfield V et al: Second primary cancers in Victoria. Melbourne: Cancer Council of Victoria Epidemiology Centre; 2009
6. Vogel VG: Identifying and screening patients at risk of second cancers. Cancer Epidemiol Biomarkers Prev, 2006; 15: 2027-32
7. Zienolddiny S, Skaug V: Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer. Lung Cancer: Targets and Therapy, 2012; 3: 1-14
8. Koutsopoulos AV, Dambaki KI, Datseris G et al: A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma-report of a case and review of the literature. World J Surg Oncol, 2005; 26: 51
9. Bae MK, Byun CS, Lee CY et al: The role of surgical treatment in second primary lung cancer. Ann Thorac Surg, 2011; 92: 256-62
10. Brewster AM, Alberg AJ, Strickland PT et al: XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev, 2004; 13: 1271-75
11. Shih CM, Lee YL, Chiou HL et al: Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer, 2006; 52: 15-20
12. Liu L, Yang X, Chen X et al: Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep, 2012; 39: 2683-88
13. Chen X, Zhang L, Chang Y et al: Association of TNF-alpha genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a Han Chinese population. Int J Biol Markers, 2011; 26: 181-87
14. Seifart C, Plagens A, Dempfle A et al: TNF-α, TNF-β, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers, 2005; 21: 157-65
15. Garza-González E, Bosques-Padilla FJ, El-Omar E et al: Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer, 2005; 114: 237-41
16. Azmy IA, Balasubramanian SP, Wilson AG et al: Role of tumour factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res, 2004; 6: 395-400
17. Liu CJ, Wong YK, Chang KW et al: Tumor necrosis factor-a promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med, 2005; 34: 608-12
18. Moertel CG: Multiple primary malignant neoplasms: historical perspectives. Cancer, 1977; 40(Suppl.4): 1786-92
19. Zhou P, Lv GQ, Wang JZ et al: The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PloS One, 2011; 6: e22092
20. Fabris M, Di Poi E, D'Elia A et al: Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatolol, 2002; 29: 29-33